FindTrial
Sign In

Remdesivir effect in the treatment of corona

Effect of Remdesivir in the treatment of Covid-19 patients- An Observational Retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/10/028657
Enrollment
275
Registered
2020-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: NIL: NIL Control Intervention1: Group A: Patients who have received remdesivir in addition to standard treatment Group B:Patients who have received only standard care( No remdesivir): G

Sponsors

Department of pharmacology
Lead Sponsor
Department of medicine
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Covid rapid test positive or Rt-PCR test positive SpO2 level less than 94% or Xray suggestive of pneumonia.

Exclusion criteria

Exclusion criteria: Patients file with incomplete details

Design outcomes

Primary

MeasureTime frame
Reduction in SpO2 level and severity score Reduction in hospital stay and ICU stay Reduction in mortality Safety profile of remdesivirTimepoint: Reduction in SpO2 level and severity score at day 1,3,5,7,10,14,21,28 Reduction in hospital stay and ICU stay at day 28 Reduction in mortality at final outcome(death or discharge of patient) Safety profile of remdesivir (till discharge or death of patients)—

Secondary

MeasureTime frame
Safety profile of remdesivirTimepoint: Till final outcome—

Countries

India

Contacts

Public ContactDr Mitul Upadhyay

Government medical college Bhavnagar

drmitulupadhyay@gmail.com9409386446

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026